These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16249593)

  • 1. The expanding role of the HMG-CoA reductase inhibitor, the most widely prescribed drug in the world.
    Futterman LG; Lemberg L
    Am J Crit Care; 2005 Nov; 14(6):555-8. PubMed ID: 16249593
    [No Abstract]   [Full Text] [Related]  

  • 2. Dyslipidaemia, statins and rheumatoid arthritis.
    Nurmohamed MT; Dijkmans BA
    Ann Rheum Dis; 2009 Apr; 68(4):453-5. PubMed ID: 19286903
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of dyslipidemia in renal disease and transplantation.
    Zolezzi M
    Saudi J Kidney Dis Transpl; 2006 Jun; 17(2):129-36. PubMed ID: 16903617
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholesterol and peripheral vascular disease: a neglected topic?
    Atar D; Jørgensen JJ
    Scand Cardiovasc J; 2007 Jun; 41(3):136-7. PubMed ID: 17487760
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic interactions between statins and fibrates.
    Corsini A; Bellosta S; Davidson MH
    Am J Cardiol; 2005 Nov; 96(9A):44K-49K; discussion 34K-35K. PubMed ID: 16291014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving cholesterol goals. Current and future drug therapies.
    Jones PH
    Postgrad Med; 2003 Aug; 114(2 Suppl):14-21. PubMed ID: 19667635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical inquiries. What are effective medication combinations for dyslipidemia?
    Saseen J; Tweed E; Crawford P
    J Fam Pract; 2006 Jan; 55(1):70-2. PubMed ID: 16388773
    [No Abstract]   [Full Text] [Related]  

  • 8. Statins are effective in treating dyslipidemia among psychiatric patients using second-generation antipsychotic agents.
    Ojala K; Repo-Tiihonen E; Tiihonen J; Niskanen L
    J Psychopharmacol; 2008 Jan; 22(1):33-8. PubMed ID: 17715204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of dyslipidemia in clinical practice].
    Paragh G; Harangi M
    Orv Hetil; 2006 Mar; 147(9):389-94. PubMed ID: 16619956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of dyslipidemia--what's left in the pipeline?
    Rau O; Zettl H; Popescu L; Steinhilber D; Schubert-Zsilavecz M
    ChemMedChem; 2008 Feb; 3(2):206-21. PubMed ID: 17963209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease.
    Poussa H; Strandberg TE; Tikkanen I; Kauhanen P; Lepäntalo M
    Scand Cardiovasc J; 2007 Jun; 41(3):138-41. PubMed ID: 17487761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
    Stein EA; Ballantyne CM; Windler E; Sirnes PA; Sussekov A; Yigit Z; Seper C; Gimpelewicz CR
    Am J Cardiol; 2008 Feb; 101(4):490-6. PubMed ID: 18312764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of dyslipidemias in patients with diabetes and chronic kidney disease.
    Molitch ME
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1090-9. PubMed ID: 17699330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing residual risk for patients on statin therapy: the potential role of combination therapy.
    Davidson MH
    Am J Cardiol; 2005 Nov; 96(9A):3K-13K; discussion 34K-35K. PubMed ID: 16291008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug insight: the role of statins in combination with ezetimibe to lower LDL cholesterol.
    Gotto AM; Farmer JA
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):664-72. PubMed ID: 17122799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin-fibrate combination therapy.
    Feeman WE
    Am J Cardiol; 2008 May; 101(10):1521. PubMed ID: 18471475
    [No Abstract]   [Full Text] [Related]  

  • 17. [Preadmission use of statins as treatment for strokes].
    González-Hernández A; López-Fernández JC; Fabre-Pi O; Cubero A
    Rev Neurol; 2007 Dec 1-15; 45(11):702-3. PubMed ID: 18050107
    [No Abstract]   [Full Text] [Related]  

  • 18. A call for development of comprehensive therapy for dyslipidemia.
    Deshpande NV; Mardikar HM; Deo D
    J Am Coll Cardiol; 2007 Apr; 49(13):1502; author reply 1502-3. PubMed ID: 17397683
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipids, statins and cardiovascular disease.
    Cheifitz R
    Climacteric; 2008 Aug; 11(4):347-8; author reply 348-50. PubMed ID: 18645702
    [No Abstract]   [Full Text] [Related]  

  • 20. Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapy.
    Polonsky TS; Davidson MH
    Am J Cardiol; 2008 Apr; 101(8A):27B-35B. PubMed ID: 18375238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.